2022, Presenter Profiles, Scientific Sessions
  • Presenter Profiles: Use of Metabolomics for Assessment of Metabolic Outcomes in Offspring Exposed to Diabetes in Utero: Steps Toward Clinical Applications

    Presenter Profiles: Use of Metabolomics for Assessment of Metabolic Outcomes in Offspring Exposed to Diabetes in Utero: Steps Toward Clinical Applications

    Wei Perng, PhD, MPH, discusses the research behind this presentation at the 82nd Scientific Sessions. Attendees in New Orleans can watch the session in-person Sunday, June 5 at 6:00 p.m. CT, and a recording can be viewed on-demand via the meeting’s virtual platform after the live presentation.


  • Presenter Profiles: COVID-19 and the Diabetic Lower Limb

    Presenter Profiles: COVID-19 and the Diabetic Lower Limb

    Windy Cole, DPM, CWSP, discusses the research behind this presentation at the 82nd Scientific Sessions. Attendees in New Orleans can watch the session in-person Saturday, June 4 at 11:35 a.m. CT, and a recording can be viewed on-demand via the meeting’s virtual platform after the live presentation.


  • Presenter Profiles: The Mitochondrial Transporter ABCB10 Promotes Beta-Cell Initiated Insulin Resistance

    Presenter Profiles: The Mitochondrial Transporter ABCB10 Promotes Beta-Cell Initiated Insulin Resistance

    Marc Liesa, PhD, discusses the research behind this presentation at the 82nd Scientific Sessions. Attendees in New Orleans can watch the session in-person Saturday, June 4 at 9:30 a.m. CT, and a recording can be viewed on-demand via the meeting’s virtual platform after the live presentation.


  • Presenter Profiles: Role of Extracellular Matrix in Mitochondrial Homeostasis

    Presenter Profiles: Role of Extracellular Matrix in Mitochondrial Homeostasis

    Kevin M. Tharp, PhD, discusses the research behind this presentation at the 82nd Scientific Sessions. Attendees in New Orleans can watch the session in-person Saturday, June 4 at 9:00 a.m. CT, and a recording can be viewed on-demand via the meeting’s virtual platform after the live presentation.


  • Presenter Profiles: SGLT2-Inhibitors for Treatment of NAFLD

    Presenter Profiles: SGLT2-Inhibitors for Treatment of NAFLD

    Mohammad S. Kuchay, MD, DM, discusses the research behind this presentation at the 82nd Scientific Sessions. Attendees in New Orleans can watch the session in-person Saturday, June 4 at 9:00 a.m. CT, and a recording can be viewed on-demand via the meeting’s virtual platform after the live presentation.


  • Presenter Profiles: Practical Approaches to Insulin Dose Adjustments While on Closed Loop

    Presenter Profiles: Practical Approaches to Insulin Dose Adjustments While on Closed Loop

    David Maahs, MD, PhD, discusses the research behind this presentation at the 82nd Scientific Sessions. Attendees in New Orleans can watch the session in-person Friday, June 3 at 4:45 p.m. CT, and a recording can be viewed on-demand via the meeting’s virtual platform after the live presentation.


  • Presenter Profiles: Peer Support to Enhance Type 2 Diabetes Prevention Among African American and Latino Adults

    Presenter Profiles: Peer Support to Enhance Type 2 Diabetes Prevention Among African American and Latino Adults

    Luis A. Rodriguez, PhD, MPH, RD, discusses the research behind this presentation at the 82nd Scientific Sessions. Attendees in New Orleans can watch the session in-person Friday, June 3 at 3:12 p.m. CT, and a recording can be viewed on-demand via the meeting’s virtual platform after the live presentation.


  • Presenter Profiles: Connected-Insulin Pen Systems Provide Critical Data to Guide Effective Insulin Therapy – Clinical Trial and Real-World Evidence in Type 1 and Type 2 Diabetes

    Presenter Profiles: Connected-Insulin Pen Systems Provide Critical Data to Guide Effective Insulin Therapy – Clinical Trial and Real-World Evidence in Type 1 and Type 2 Diabetes

    Viral N. Shah, MD, discusses the research behind this presentation at the 82nd Scientific Sessions. Attendees in New Orleans can watch the session in-person Friday, June 3 at 3:00 p.m. CT, and a recording can be viewed on-demand via the meeting’s virtual platform after the live presentation.


  • Presenter Profiles: Beyond Cardio-Renal Benefits of SGLT2 Inhibitors & GLP-1 RAs: Why Aren’t Neuropathy Outcomes Included in Current Major Outcomes Trials?

    Presenter Profiles: Beyond Cardio-Renal Benefits of SGLT2 Inhibitors & GLP-1 RAs: Why Aren’t Neuropathy Outcomes Included in Current Major Outcomes Trials?

    Hertzel C. Gerstein, MD, MSc, FRCPC, discusses the research behind this presentation at the 82nd Scientific Sessions. Attendees in New Orleans can watch the session in-person Friday, June 3 at 12:45 p.m. CT, and a recording can be viewed on-demand via the meeting’s virtual platform after the live presentation.


  • Presenter Profiles: Innovations in Diabetes Foot Complication Translational Research

    Presenter Profiles: Innovations in Diabetes Foot Complication Translational Research

    Laura Shin, DPM, PhD, discusses the research behind this presentation at the 82nd Scientific Sessions. Attendees in New Orleans can watch the session in-person Friday, June 3 at 11:30 a.m. CT, and a recording can be viewed on-demand via the meeting’s virtual platform after the live presentation.